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SCIENTIFIC OPINION  
Scientific Opinion on the safety and efficacy of AveMix
® XG 10 (endo-1,4-
beta-xylanase and endo-1,3(4)-beta-glucanase) as a feed additive for pigs for 
fattening and minor porcine species
1 
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
The additive AveMix
® XG 10 is an enzyme preparation of endo-1,4-beta-xylanase (xylanase) and endo-1,3(4)-
beta-glucanase (glucanase), produced by two strains of Trichoderma reesei. This product is currently authorised 
for  use  in  chickens  for  fattening,  laying  hens,  minor  poultry  species  and  weaned  piglets  as  a  zootechnical 
additive, under the functional group of digestibility enhancers. The applicant is now seeking an extension of the 
authorisation to pigs for fattening and minor porcine species at a recommended dose of 4 000 XU (xylanase 
units) and 900 BGU (beta-glucanase units) per kg complete feed. The FEEDAP Panel considers that, since the 
additive has been demonstrated to be safe for piglets at the recommended dose, this conclusion can be extended 
to pigs for fattening and extrapolated to minor growing porcine species. Supplementation of diets for pigs for 
fattening with Avemix
® XG 10 at the recommended dose (4 000 XU and 900 BGU/kg) resulted in a significantly 
higher body weight and daily weight gain in one trial and significantly improved feed to gain ratio in two trials. 
Therefore, the FEEDAP Panel concludes that AveMix
® XG 10 has the potential to be efficacious in pigs for 
fattening at this dose. Since the mode of action of xylanases and glucanases can reasonably be assumed to be the 
same  in  all  porcine  species,  the  conclusions  on  efficacy  for  weaned  piglets  and  pigs  for  fattening  can  be 
extrapolated to include all minor porcine species for growing at 4 000 XU and 900 BGU/kg complete feed. 
© European Food Safety Authority, 2013 
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SUMMARY 
Following  a  request  from  the  European  Commission,  the  Panel  on  Additives  and  Products  or 
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the safety and 
efficacy of AveMix
® XG 10 (endo-1,4-beta-xylanase, endo-1,3(4)-beta-glucanase) as a feed additive 
for pigs for fattening and minor porcine species. 
The additive AveMix
® XG 10 is an enzyme preparation of endo-1,4-beta-xylanase (xylanase) and 
endo-1,3(4)-beta-glucanase (glucanase), produced by two strains of Trichoderma reesei. This product 
is currently authorised for use in chickens for fattening, laying hens, minor poultry species and weaned 
piglets as a zootechnical additive, under the functional group of digestibility enhancers. The applicant 
is now seeking an extension of the authorisation to pigs for fattening and minor porcine species at a 
recommended dose of 4 000 XU and 900 BGU/kg complete feed.  
A full description of the formulations, manufacturing processes, purity, stability and homogeneity of 
the product has already been provided in a previous assessment. The FEEDAP Panel considers that the 
safety  aspects  other  than  safety  for  the  new  target  species  have  been  covered  in  the  previous 
assessment  and  would  not  be  affected  by  the  requested  extension  of  use.  Therefore,  the  present 
opinion focuses only on the safety and efficacy of this enzyme preparation for the new target species. 
The applicant provided a tolerance study performed in weaned piglets that was previously evaluated 
by  the  FEEDAP  Panel.  In  this  study  the  piglets  tolerated  well  a  100-fold  overdose  of  the 
recommended dose (4 000 XU and 900 BGU/kg feed) and therefore the Panel concluded that the 
additive is safe for weaned piglets when used at the recommended dose. The FEEDAP Panel considers 
that conclusions reached in piglets can be extended to pigs for fattening, provided that the same 
maximum dose applies. The conclusions on the tolerance in piglets can be extrapolated to include all 
minor growing porcine species at 4 000 XU and 900 BGU/kg complete feed. 
Three efficacy studies performed in pigs for fattening were provided. The supplementation of the diets 
with  Avemix
®  XG  10  at  the  recommended  dose  (4 000  XU  and  900  BGU/kg)  resulted  in  a 
significantly higher body weight and daily weight gain in one trial and in a significantly improved feed 
to gain ratio in two trials. Therefore, the FEEDAP Panel concludes that AveMix
® XG 10 has the 
potential to be efficacious in pigs for fattening at the dose of 4 000XU and 900 BGU/kg feed. Since 
the mode of action of xylanases and glucanases can be reasonably assumed to be the same in all 
porcine  species,  the  conclusions  on  the  efficacy  in  weaned  piglets  and  pigs  for  fattening  can  be 
extrapolated to include all minor growing porcine species at 4 000 XU and 900 BGU/kg complete 
feed. AveMix
® XG 10 for pigs  
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BACKGROUND  
Regulation  (EC)  No  1831/2003
4  establishes the rules governing the Community authorisation of 
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any 
person seeking authorisation for a feed additive or for a  new use of a feed additive shall submit an 
application in accordance with Article 7.  
The European Commission received a request from the company AVEVE NV
5 for authorisation of the 
product AveMix
® XG 10, endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase, when used as a 
feed  additive  for  pigs  for  fattening  and  minor  porcine  species  (category:  zootechnical  additives; 
functional group: digestibility enhancers) under the conditions mentioned in Table 1.  
According  to  Article  7(1)  of  Regulation  (EC)  No  1831/2003,  the  Commission  forwarded  the 
application  to  the  European  Food  Safety  Authority  (EFSA)  as  an  application  under  Article  4(1) 
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the 
applicant  the  technical  dossier  in  support  of  this  application.
6  According  to  Article  8  of  that 
Regulation, EFSA, after verifying the particulars and documents submitted by the applicant, shall 
undertake an assessment in order to determine whether the feed additive complies with the conditions 
laid down in Article 5. The particulars and documents in support of the application were considered 
valid by EFSA as of 22 August 2012. 
The additive AveMix
® XG 10 is a preparation of endo-1,4-beta-xylanase produced by Trichoderma 
reesei  (MUCL  49755)  and  endo-1,3(4)-beta-glucanase  produced  by  Trichoderma  reesei  (MUCL 
49754).  This  product  is  currently  authorised  for  use  as  feed  additive  in  feed  for  chickens  for 
fattening,
7,8 weaned piglets
9 and laying hens and minor poultry species for fattening and laying.
10 
The European Food Safety Authority issued a scientific opinion on the safety and efficacy of AveMix
® 
XG 10 as a feed additive for chickens for fattening (EFSA, 2009) and one on the modification of the 
terms of the authorisation of the product for this species (EFSA, 2010). Opinions on the safety and 
efficacy of the product as a feed additive for weaned piglets and laying hens and minor poultry species 
were published on 2011 and 2012, respectively (EFSA, 2011 and 2012).  
TERMS OF REFERENCE  
According to Article 8 of Regulation (EC) No 1831/2003, EFSA shall determine whether the feed 
additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on the 
safety for the target animals, consumer, user and the environment and the efficacy of the product 
                                                       
4   Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use 
in animal nutrition. OJ L 268, 18.10.2003, p. 29. 
5   AVEVE NV, Eugeen Meeusstraat 6, 2170 Merksem, Belgium. 
6   EFSA Dossier reference: FAD-2012-0022. 
7  Commission Regulation (EC) No 1091/2009 of 13 November 2009 concerning the authorisation of an enzyme preparation 
of endo-1,4-beta-xylanase produced by Trichoderma reesei (MUCL 49755) and endo-1,3(4)-beta-glucanase produced by 
Trichoderma reesei (MUCL 49754) as a feed additive for chickens for fattening (holder of authorisation Aveve NV) OJ L 
299, 14.11.2009, p. 6. 
8  Commission Regulation (EU) No 335/2011  of 7 April 2011 amending Regulation (EC) No 1091/20 09 as regards the 
minimum content of the enzyme preparation of endo -1,4-beta-xylanase produced by Trichoderma reesei (MUCL 49755) 
and endo-1,3(4)-beta-glucanase produced by Trichoderma reesei (MUCL 49754) as a feed additive in feed for chickens for 
fattening OJ L 94, 08.04.2011, p. 14. 
9  Commission Implementing Regulation (EU) No 1088/2011 of 27 October 2011 concerning the authorisation of an enzyme 
preparation of endo-1,4-beta-xylanase produced by Trichoderma reesei (MUCL 49755) and endo-1,3(4)-beta-glucanase 
produced by Trichoderma reesei (MUCL 49754) as a feed additive for weaned piglets (holder of authorisation Aveve NV) 
OJ L 281, 28.10.2011, p. 14. 
10 Commission Implementing Regulation (EU) No 989/2012 of 25 October 2012 concerning the authorisation of  endo-1,4-
beta-xylanase produced by Trichoderma reesei (MUCL 49755) and endo-1,3(4)-beta-glucanase produced by Trichoderma 
reesei (MUCL 49754) as a feed additive for laying hens and minor poultry species for fattening and laying (holder of 
authorisation Aveve NV). OJ L 297, 26.10.2012, p. 11. AveMix
® XG 10 for pigs  
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®  XG  10,  endo-1,4-beta-xylanase  and  endo-1,3(4)-beta-glucanase,  when  used  under  the 
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Table 1:   Description and conditions of use of the additive as proposed by the applicant  
Additive   endo-1,4-beta-xylanase  EC  3.2.1.8  and  endo-1,3(4)-beta-glucanase  EC 
3.2.1.6 (AveMix
® XG 10) 
Registration number/EC 
No/No (if appropriate)  4a9 
Category(-ies) of additive  Zootechnical additive 
Functional group(s) of additive  Digestibility enhancer 
 
Description 
Composition, description  Chemical 
formula 
Purity criteria 
(if appropriate) 
Method of analysis 
(if appropriate) 
Enzyme preparation containing 
endo-1,4-beta-xylanase (EC 
3.2.1.8) produced by 
Trichoderma reesei and endo-
1,3(4)-beta-glucanase (EC 
3.2.1.6) produced by 
Trichoderma reesei. Solid or 
liquid having a minimum 
activity of endo-1,4-beta-
xylanase: 40000 XU/g endo-1,3-
(4)-beta-glucanase: 9000 BGU/g 
Not applicable 
Complies  with  JECFA 
guidelines on microbial 
quality,  heavy  metals, 
toxins  and  undesirable 
substances 
Assay based on colometric 
reaction  of  dinitrosalicylic 
acid  on  reducing  sugar 
yield produced by action of 
endo-1,4-beta-xylanase on a 
xylan  containing  substrate 
or  endo-1,3(4)-beta-
glucanase on a beta-glucan 
containing substrate 
 
Trade name (if appropriate)  AveMix
® XG 10 
Name of the holder of 
authorisation (if appropriate)  AVEVE NV 
 
Conditions of use 
Species or 
category of animal 
Maximum 
Age 
Minimum content  Maximum content  Withdrawal 
period 
(if appropriate)  U/kg of complete feedingstuffs 
Pigs  for  fattening 
and minor porcine 
species 
Until 
slaughter 
age 
Endo-1,4-beta-
xylanase:  4000  XU/kg 
complete feed endo-1,3-
(4)-beta-glucanase:  900 
BGU/kg complete feed 
  Not relevant 
 
Other provisions and additional requirements for the labeling 
Specific conditions or restrictions for 
use (if appropriate) 
In the directions for use of the additive and premixture, indicate the 
storage temperature, storage life, and stability to pelleting 
Specific conditions or restrictions for 
handling (if appropriate)  - 
Post-market monitoring  
(if appropriate)  - 
Specific conditions for use in 
complementary feedingstuffs  
(if appropriate) 
Recommended dosages per kilogram of complete feedingstuff for 
pigs  for  fattening  and  minor  porcine  species:  endo-1,4-beta-
xylanase: 4000 XU, endo-1,3(4)-beta-glucanase: 900 BGU 
 
Maximum Residue Limit (MRL) (if appropriate) 
Marker residue  Species or category of 
animal 
Target tissue(s) or 
food products 
Maximum content in 
tissues 
-  -  -  - AveMix
® XG 10 for pigs  
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ASSESSMENT 
1.  Introduction 
The additive AveMix
® XG 10 is an enzyme preparation of endo-1,4-beta-xylanase (xylanase; EC 
3.2.1.8)  and  endo-1,3(4)-beta-glucanase  (glucanase;  EC  3.2.1.6),  produced  by  two  strains  of 
Trichoderma reesei (MUCL 49755 and 49754, respectively). The product is produced in two forms, 
solid and liquid, with an activity of xylanase of 40 000 XU/g and of glucanase of 9 000 BGU/g. This 
product is currently authorised for its use in feed for chickens for fattening, laying hens and minor 
poultry  species  and  weaned  piglets  as  a  zootechnical  additive,  under  the  functional  group  of 
digestibility enhancers. The applicant is now seeking the authorisation of the product as feed additive 
for pigs for fattening and minor porcine species at a recommended dose of 4 000 XU (xylanase units) 
and 900 BGU (beta-glucanase units) per kg complete feed (delivered by 100 mg additive/kg feed). 
The European Food Safety Authority issued two scientific opinions on the safety and efficacy of 
AveMix
® XG 10 as a feed additive for chickens for fattening (EFSA, 2009, 2010), another one for its 
use in weaned piglets (EFSA, 2011) and a fourth for its use in laying hens and minor poultry species 
(EFSA, 2012). A full description of the formulations, manufacturing processes, purity, stability and 
homogeneity of the product has already been provided in a previous assessment (EFSA, 2009). The 
FEEDAP Panel considers that the safety aspects other than safety for the new target species have been 
covered in a previous assessment (EFSA, 2009) and would not be affected by the requested extension 
of  use.  Therefore,  the  present  opinion  focuses  only  on  the  safety  and  efficacy  of  this  enzyme 
preparation for the new target species.  
2.  Evaluation of the analytical methods by the  European Union Reference Laboratory 
(EURL) 
The EURL considered that the conclusions and recommendations reached in the previous assessment 
are valid and applicable for the current application.
11  
3.  Safety for pigs for fattening and minor porcine species 
The applicant provided a tolerance study performed with weaned piglets that was previously evaluated 
by the FEEDAP Panel (EFSA, 2011). In this study the piglets tolerated well a 100-fold overdose of the 
recommended dose (4 000 XU and 900 BGU/kg feed) and therefore the Panel concluded that the 
additive is safe for weaned piglets when used at the recommended dose. 
The FEEDAP Panel considers that conclusions reached in piglets can be extended to pigs for fattening, 
provided that the same maximum dose applies. The conclusions on the tolerance in piglets can be 
extrapolated to include all minor growing porcine species at the dose of 4 000 XU and 900 BGU/kg 
complete feed. 
4.  Efficacy  
4.1.  Efficacy for pigs for fattening 
Three performance trials carried out in two different countries were provided and the design of the 
trials can be found in Table 2 and a summary of the results in Table 3.  
The initial mean body weight of the pigs for fattening ranged from 27 to 32 kg. The animals were 
penned individually in trial 1 (72 males, 36 replicates per group) and in groups of 12 pigs in trials 2 
and 3 (blocking according to sex, body weight and litter origin, 12 replicates per treatment). The 
dietary treatments resulted from the supplementation of grower and finisher diets with AveMix
® XG 
                                                       
11 The  full  report  is  available on  the  EURL  website:  http://irmm.jrc.ec.europa.eu/SiteCollectionDocuments/FinRep-FAD-
2009-0062.pdf AveMix
® XG 10 for pigs  
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10 (solid formulation) to provide 0 or 4 000 XU and 900 BGU per kg feed (confirmed by analyses). 
Diets were offered in pelleted form for at least 91 days (Table 2). In trial 3 the animals had a 10-day 
adaptation period before the start of the trial. Trials 2 and 3 finished when animals reached slaughter 
body weight (112 and 119 kg, respectively). General health status and mortality were monitored and 
performance was measured. In the third trial, carcass parameters at slaughter were also measured (data 
not shown). For each experiment, the statistical approach involved an analysis of variance (ANOVA) 
(randomised block design using the pen as experimental unit). 
Table 2:   Summary of the design of the three performance trials in pigs for fattening considered for 
the assessment 
Trial 
AveMix
® XG 10 (U/kg)
1  Diet 
composition
  
Animal 
breed
2 
(sex)
  
Total no of animals 
(animals/replicate) 
replicates/treatment 
Duration 
(days)
   Intended  Analysed 
1
12  0/0 
4 000/900 
62/290 
4 427/1 252 
Wheat, barley, 
soya bean 
meal 
Cross-
breed 
(♂) 
72 
(1) 
36 
91 
2
13  0/0  
4 000/900 
829/594 
5 195/1 546 
Wheat, barley, 
soya bean 
meal 
Cross-
breed  
(♂,♀) 
288 
(12) 
12 
96 
3
14  0/0  
4 000/900 
1 226/555 
5 631/1 544 
Wheat, barley, 
soya bean 
meal 
Cross-
breed  
(♂,♀) 
288 
(12) 
12 
99 
1  Values for xylanase (XU)/glucanase (BGU), the analysed values are mean values for grower and finisher diets. 
2  Cross-breed: Duroc × Landrace in trial 1, Tempo × (Dutch Landrace × Great Yorkshire) in trial 2 and Tempo   Great 
Yorkshire breed in trial 3. 
 
The results showed that Avemix
® XG 10 at 4 000 XU/900 BGU significantly increased final weight 
and daily weight gain in one trial (trial 1), while feed to gain ratio was significantly decreased in two 
other trials (trials 2 and 3; Table 3). Mortality and culling rate were within the normal range and not 
related to the dietary treatments. In trials 2 and 3 a total of 21 and 16 pigs, respectively, required 
medical treatment during the study for different reasons (pneumonia, arthritis, diarrhoea), but were 
distributed in proportion between the dietary groups. Therefore, the Panel concludes that the additive 
has the potential to improve the performance of pigs for fattening at the recommended dose. 
Table 3:   Effect of AveMix
® XG 10 on the performance of pigs for fattening 
Trial  AveMix
® XG 10 
(U/kg)
1 
Body weight (kg)  Daily 
weight gain 
(g) 
Feed to 
gain ratio 
Mortality/culled
2 
(n) 
Initial   Final 
1  0/0 
4 000/900 
28.9 
28.9 
102.8
a 
108.5
b 
812
a 
875
b 
2.58 
2.51 
0/0 
0/1 
2  0/0 
4 000/900 
27.0 
27.0 
112.1 
112.4 
886 
890 
2.59
a 
2.56
b 
0/0 
3/0 
3  0/0 
4 000/900 
32.3 
32.2 
118.9 
118.9 
880 
874 
2.69
a 
2.62
b 
0/0 
3/3 
1 Intended dose for xylanase (XU)/glucanase (BGU).  
2 In trial 3, three piglets had to be culled at the beginning of the study; the difference in number of piglets per pen was 
considered in the statistical analysis of the study. 
a,b Values within one column and within a given trial with different superscripts are significantly different (P < 0.05). 
 
                                                       
12   Technical dossier/Section IV/Annex IV.2.11. 
13   Technical dossier/Section IV/Annex IV.2.12. 
14   Technical dossier/Section IV/Annex IV.2.13. AveMix
® XG 10 for pigs  
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4.2.  Efficacy for minor porcine species 
The additive has the potential to improve the performance of piglets (EFSA, 2011) and of pigs for 
fattening at the dose of 4 000 XU and 900 BGU per kg feed. Since the mode of action of xylanases 
and glucanases can reasonably  be assumed to be the same in all pig species, the conclusions on 
efficacy for weaned piglets and pigs for fattening can be extrapolated to include all minor growing pig 
species at the dose of 4 000 XU and 900 BGU/kg complete feed. 
5.  Post-market monitoring 
The  FEEDAP  Panel  considers  that  there  is  no  need  for  specific  requirements  for  a  post-market 
monitoring  plan  other  than  those  established  in  the  Feed  Hygiene  Regulation
15  and  Good 
Manufacturing Practice. 
CONCLUSIONS  
The two formulations (liquid and solid) of the additive are considered to be equivalent regarding the 
safety and efficacy for the target species when used at the same level. 
The FEEDAP Panel considers that, since the additive has been demonstrated to be safe for piglets at 
the recommended dose, this conclusion can be extended to pigs for fattening and extrapolated to all 
minor growing porcine species provided that the same dose applies. 
Supplementation of the feed for pigs for fattening with Avemix
® XG 10 at the proposed dose (4 000 
XU  and  900  BGU/kg)  resulted  in  a  better  performance  of  the  pigs  for  fattening  in  three  trials. 
Therefore, the FEEDAP Panel concludes that AveMix
® XG 10 has the potential to be efficacious in 
pigs for fattening at this supplementation level. Since the mode of action of xylanases and glucanases 
can be reasonably assumed to be the same in all porcine species, the conclusions on efficacy for 
weaned piglets and pigs for fattening can be extrapolated to include all minor growing porcine species 
at the dose of 4 000 XU and 900 BGU/kg complete feed. 
DOCUMENTATION PROVIDED TO EFSA 
1.  AveMix
® XG 10 pigs for fattening and minor porcine species. June 2012. Submitted by AVEVE 
NV. 
2.  AveMix
® XG 10 pigs for fattening and minor porcine species. December 2012. Submitted by 
AVEVE NV. 
3.  Comments from Member States received through the ScienceNet. 
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